Cardlytics Cost Of Revenue from 2010 to 2025

CDLX Stock  USD 3.06  0.10  3.16%   
Cardlytics Cost Of Revenue yearly trend continues to be fairly stable with very little volatility. Cost Of Revenue will likely drop to about 132.5 M in 2025. During the period from 2010 to 2025, Cardlytics Cost Of Revenue regression line of annual values had r-squared of  0.81 and arithmetic mean of  105,307,057. View All Fundamentals
 
Cost Of Revenue  
First Reported
2015-06-30
Previous Quarter
39.8 M
Current Value
38.5 M
Quarterly Volatility
11.8 M
 
Yuan Drop
 
Covid
Check Cardlytics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardlytics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 3.4 M or Depreciation And Amortization of 35.6 M, as well as many indicators such as Price To Sales Ratio of 0.93, Dividend Yield of 0.0 or PTB Ratio of 3.76. Cardlytics financial statements analysis is a perfect complement when working with Cardlytics Valuation or Volatility modules.
  
Check out the analysis of Cardlytics Correlation against competitors.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Latest Cardlytics' Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of Cardlytics over the last few years. Cost of Revenue is found on Cardlytics income statement and represents the costs associated with goods and services Cardlytics provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is Cardlytics' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardlytics' overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Slightly volatile
   Cost Of Revenue   
       Timeline  

Cardlytics Cost Of Revenue Regression Statistics

Arithmetic Mean105,307,057
Geometric Mean92,362,233
Coefficient Of Variation52.39
Mean Deviation48,015,689
Median96,003,000
Standard Deviation55,169,573
Sample Variance3043.7T
Range153.2M
R-Value0.90
Mean Square Error607.6T
R-Squared0.81
Slope10,452,741
Total Sum of Squares45655.2T

Cardlytics Cost Of Revenue History

2025132.5 M
2024205.6 M
2023178.8 M
2022185.9 M
2021163.8 M
2020123.6 M
2019131 M

About Cardlytics Financial Statements

Cardlytics investors use historical fundamental indicators, such as Cardlytics' Cost Of Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cardlytics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue205.6 M132.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.